Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

NCT05499416 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor decision.

Conditions

Psoriasis Vulgaris
Active Psoriatic Arthritis

Interventions

DRUG: Bimekizumab

Sponsor

Innovaderm Research Inc.

Collaborators

[object Object]